Market Cap 5.53B
Revenue (ttm) 1.61B
Net Income (ttm) 282.33M
EPS (ttm) N/A
PE Ratio 37.61
Forward PE 26.46
Profit Margin 17.53%
Debt to Equity Ratio 0.00
Volume 64,745,700
Avg Vol 41,299,867
Day's Range N/A - N/A
Shares Out 518.12M
Stochastic %K 85%
Beta 0.96
Analysts Sell
Price Target $13.00

Company Profile

UiPath, Inc. provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. It offers the UiPath platform, an integrated enterprise software platform that enables AI agents, robots, people, and models to work together in coordinated workflows. The company's UiPath platform includes the UiPath Maestro process orchestration and process intelligence; UiPath agent bui...

Industry: Software - Infrastructure
Sector: Technology
Phone: 844 432 0455
Address:
One Vanderbilt Avenue, 60th Floor, New York, United States
cor1
cor1 Jul. 1 at 4:17 AM
0 · Reply
Beebee12
Beebee12 Jul. 1 at 2:36 AM
$PATH what kind of target here? Looking to pick some up thanks
1 · Reply
IdeletedRobinhood
IdeletedRobinhood Jul. 1 at 2:22 AM
$PATH Your (flawed, IMO) reasoning is the reason PATH’s short interest is so high - and why PATH is a sleeping/misunderstood opportunity Anthropic’s acquisition of Vercept last February does enable some smaller businesses to build more simple agent processes - but it is really a threat to is UiPaths legacy RPA business, which UiPath is transitioning from Maestro, what UiPath is transitioning to, is a grand orchestration layer which links all models and enables governance at enterprise scale In larger Agentic AI processes, utilizing multiple models to cost engineer is crucial - especially with rising token costs Multi-model cost engineering requires an external layer - such as UiPath Maestro UiPath succeeds if Agentic AI succeeds - it doesn’t matter which model(s) succeed It’s the difference between investing in a stock, or being the stock broker - the stock broker wins no matter what the stocks do
2 · Reply
justcomments
justcomments Jul. 1 at 2:01 AM
$PATH my company is using COPILOT and I have a pleasure of speaking with it from time to time and it is sometimes a true waste of time. Last week I requested a pinout of some connector that was not easy to identify and this ai simply made up part numbers and information. I was shocked. It is one thing when ai makes up stories out there for other people and entirely different experience when it does that right in front of you on a company approved system. For my personal use I signed up for Claude and I am paying for it. When somebody tells me that Microsoft can be a competing product to something - I'd say - wait for competition to show up.
0 · Reply
IdeletedRobinhood
IdeletedRobinhood Jul. 1 at 12:55 AM
$GRRR $PATH $20-$25 max ceiling for PATH? What is your evidence? GRRR is currently trading at an EV/Revenue multiple of about 4x PATH is trading at an EV/Revenue multiple of about 2.5x - and revenue will likely explode in the upcoming quarters due to Maestro One big government contract at PATH (coming IMO) and the revenue growth could ultimately command a multiple of 7x-8x Factoring in both increased revenue, and a higher multiple, and $50+ is in the cards in 2027 IMO - not to mention the current short interest of 30%+ PATH could trade close to $20 tomorrow and still be more undervalued than GRRR I hope GRRR goes well for everyone invested, but let’s be honest, GRRR management has a history of making grandiose announcements - and the announcements not materializing as claimed Regardless - GL 🍻
4 · Reply
Carl2233
Carl2233 Jul. 1 at 12:42 AM
$PATH Most simply don't understand this or ignore this reality.
0 · Reply
ScreamLikeABaby
ScreamLikeABaby Jul. 1 at 12:20 AM
$PATH Investors need to understand that raw AI models make mistakes. An AI can confidently hallucinate and click the wrong button inside a banking app, accidentally wire $10 million to the wrong account, or delete a patient's medical history. UiPath WILL be the brakes, steering wheel, and seatbelts for AI. Big Tech can build their big scary roaring engine all they want, but corporations (Banking, Healthcare industry) will not turn that engine on unless UiPath is in the driver's seat ensuring the AI operates safely, follows regulations, and logs every single move for auditors. Uipath is NOT being replaced!
0 · Reply
SanKish
SanKish Jun. 30 at 11:57 PM
$AMZN $META $MSFT $PATH $SPY I have been selling CCs for UIPath and it has never been exercised yet. When will it break out ? Doesn’t look like based on past data.
0 · Reply
SouthernItUp
SouthernItUp Jun. 30 at 11:55 PM
$PATH IPO was a tad high
1 · Reply
FOREMC
FOREMC Jun. 30 at 11:54 PM
$PATH $PATH $ASTS $GRRR $POET you will probably make more buying grrr again at 20 - such a bonehead play buying path with max 20-25 ceiling
0 · Reply
Latest News on PATH
UiPath price target lowered to $12 from $13 at UBS

2026-06-29T12:50:45.000Z - 1 day ago

UiPath price target lowered to $12 from $13 at UBS


UiPath Transcript: AGM 2026

Jun 25, 2026, 11:00 AM EDT - 5 days ago

UiPath Transcript: AGM 2026


UiPath announces Maestro Case capability

2026-06-16T12:36:04.000Z - 14 days ago

UiPath announces Maestro Case capability


UiPath price target lowered to $13 from $14 at BMO Capital

2026-06-01T13:44:26.000Z - 4 weeks ago

UiPath price target lowered to $13 from $14 at BMO Capital


UiPath price target raised to $13 from $12 at BofA

2026-05-29T13:25:05.000Z - 4 weeks ago

UiPath price target raised to $13 from $12 at BofA


UiPath price target lowered to $15 from $17 at Morgan Stanley

2026-05-29T11:54:44.000Z - 4 weeks ago

UiPath price target lowered to $15 from $17 at Morgan Stanley


UiPath Earnings Call Transcript: Q1 2027

May 28, 2026, 5:00 PM EDT - 4 weeks ago

UiPath Earnings Call Transcript: Q1 2027


UiPath Earnings release: Q1 2027

May 28, 2026, 5:00 PM EDT - 4 weeks ago

UiPath Earnings release: Q1 2027


UiPath Slides: Q1 2027

May 28, 2026, 5:00 PM EDT - 4 weeks ago

UiPath Slides: Q1 2027


UiPath Quarterly report: Q1 2027

May 28, 2026, 5:00 PM EDT - 4 weeks ago

UiPath Quarterly report: Q1 2027


UiPath Reports First Quarter Fiscal 2027 Financial Results

May 28, 2026, 4:10 PM EDT - 4 weeks ago

UiPath Reports First Quarter Fiscal 2027 Financial Results


UiPath Proxy statement: Proxy filing

May 22, 2026, 8:00 AM EDT - 5 weeks ago

UiPath Proxy statement: Proxy filing


UiPath Proxy statement: Proxy filing

May 12, 2026, 8:00 AM EDT - 7 weeks ago

UiPath Proxy statement: Proxy filing


UiPath Proxy statement: Proxy filing

May 12, 2026, 8:00 AM EDT - 7 weeks ago

UiPath Proxy statement: Proxy filing


UiPath Transcript: Status update

Apr 6, 2026, 11:30 AM EDT - 3 months ago

UiPath Transcript: Status update


UiPath stock: why sell-off makes sense despite Q4 beat and buyback

Mar 12, 2026, 12:48 PM EDT - 3 months ago

UiPath stock: why sell-off makes sense despite Q4 beat and buyback


UiPath Earnings Call Transcript: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 3 months ago

UiPath Earnings Call Transcript: Q4 2026


UiPath Annual report: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 3 months ago

UiPath Annual report: Q4 2026


UiPath Earnings release: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 3 months ago

UiPath Earnings release: Q4 2026


UiPath Slides: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 3 months ago

UiPath Slides: Q4 2026


UiPath Annual report: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 3 months ago

UiPath Annual report: Q4 2026


UiPath Profit, Revenue Rise as AI Adoption Spreads

Mar 11, 2026, 4:57 PM EDT - 3 months ago

UiPath Profit, Revenue Rise as AI Adoption Spreads


UiPath Transcript: 28th Annual Needham Growth Conference Virtual

Jan 13, 2026, 11:00 AM EST - 6 months ago

UiPath Transcript: 28th Annual Needham Growth Conference Virtual


UiPath Earnings Show Accelerating Growth

Dec 4, 2025, 3:50 PM EST - 7 months ago

UiPath Earnings Show Accelerating Growth


UiPath Stock Soars. It's Looking More Like an AI Winner.

Dec 4, 2025, 10:47 AM EST - 7 months ago

UiPath Stock Soars. It's Looking More Like an AI Winner.


cor1
cor1 Jul. 1 at 4:17 AM
0 · Reply
Beebee12
Beebee12 Jul. 1 at 2:36 AM
$PATH what kind of target here? Looking to pick some up thanks
1 · Reply
IdeletedRobinhood
IdeletedRobinhood Jul. 1 at 2:22 AM
$PATH Your (flawed, IMO) reasoning is the reason PATH’s short interest is so high - and why PATH is a sleeping/misunderstood opportunity Anthropic’s acquisition of Vercept last February does enable some smaller businesses to build more simple agent processes - but it is really a threat to is UiPaths legacy RPA business, which UiPath is transitioning from Maestro, what UiPath is transitioning to, is a grand orchestration layer which links all models and enables governance at enterprise scale In larger Agentic AI processes, utilizing multiple models to cost engineer is crucial - especially with rising token costs Multi-model cost engineering requires an external layer - such as UiPath Maestro UiPath succeeds if Agentic AI succeeds - it doesn’t matter which model(s) succeed It’s the difference between investing in a stock, or being the stock broker - the stock broker wins no matter what the stocks do
2 · Reply
justcomments
justcomments Jul. 1 at 2:01 AM
$PATH my company is using COPILOT and I have a pleasure of speaking with it from time to time and it is sometimes a true waste of time. Last week I requested a pinout of some connector that was not easy to identify and this ai simply made up part numbers and information. I was shocked. It is one thing when ai makes up stories out there for other people and entirely different experience when it does that right in front of you on a company approved system. For my personal use I signed up for Claude and I am paying for it. When somebody tells me that Microsoft can be a competing product to something - I'd say - wait for competition to show up.
0 · Reply
IdeletedRobinhood
IdeletedRobinhood Jul. 1 at 12:55 AM
$GRRR $PATH $20-$25 max ceiling for PATH? What is your evidence? GRRR is currently trading at an EV/Revenue multiple of about 4x PATH is trading at an EV/Revenue multiple of about 2.5x - and revenue will likely explode in the upcoming quarters due to Maestro One big government contract at PATH (coming IMO) and the revenue growth could ultimately command a multiple of 7x-8x Factoring in both increased revenue, and a higher multiple, and $50+ is in the cards in 2027 IMO - not to mention the current short interest of 30%+ PATH could trade close to $20 tomorrow and still be more undervalued than GRRR I hope GRRR goes well for everyone invested, but let’s be honest, GRRR management has a history of making grandiose announcements - and the announcements not materializing as claimed Regardless - GL 🍻
4 · Reply
Carl2233
Carl2233 Jul. 1 at 12:42 AM
$PATH Most simply don't understand this or ignore this reality.
0 · Reply
ScreamLikeABaby
ScreamLikeABaby Jul. 1 at 12:20 AM
$PATH Investors need to understand that raw AI models make mistakes. An AI can confidently hallucinate and click the wrong button inside a banking app, accidentally wire $10 million to the wrong account, or delete a patient's medical history. UiPath WILL be the brakes, steering wheel, and seatbelts for AI. Big Tech can build their big scary roaring engine all they want, but corporations (Banking, Healthcare industry) will not turn that engine on unless UiPath is in the driver's seat ensuring the AI operates safely, follows regulations, and logs every single move for auditors. Uipath is NOT being replaced!
0 · Reply
SanKish
SanKish Jun. 30 at 11:57 PM
$AMZN $META $MSFT $PATH $SPY I have been selling CCs for UIPath and it has never been exercised yet. When will it break out ? Doesn’t look like based on past data.
0 · Reply
SouthernItUp
SouthernItUp Jun. 30 at 11:55 PM
$PATH IPO was a tad high
1 · Reply
FOREMC
FOREMC Jun. 30 at 11:54 PM
$PATH $PATH $ASTS $GRRR $POET you will probably make more buying grrr again at 20 - such a bonehead play buying path with max 20-25 ceiling
0 · Reply
WunDumFuc
WunDumFuc Jun. 30 at 11:52 PM
$PATH $SPY $AMZN $MSFT $META UiPATH single most stock in whole market poised for 10X
0 · Reply
AZ_09
AZ_09 Jun. 30 at 11:46 PM
$PATH $ASTS $GRRR $POET Absolutely 💯
0 · Reply
Carl2233
Carl2233 Jun. 30 at 9:45 PM
$PATH 1/3rd the float is short... Short Interest % Float 32.79 % - source: NYSE (Short Interest), Capital IQ (float) Short Interest 126,248,835 Shares - source: NYSE Trading Volume continues to increase... I am long
0 · Reply
beanbamba
beanbamba Jun. 30 at 9:25 PM
$PATH this needs a heavy buy and once the short squeeze starts then it will be above 100$. But the MMs have unlimited shares to short it and don’t let it go up. This will eventually explode and shorts will lose their shorts
1 · Reply
ScreamLikeABaby
ScreamLikeABaby Jun. 30 at 8:46 PM
$PATH Gaining strength 💪
0 · Reply
Spy0DTEs
Spy0DTEs Jun. 30 at 8:43 PM
$NKE this is going to pull a $PATH. Similar earnings, similar initial reaction. Calls at open tomorrow and enjoy the ride.
1 · Reply
elprup
elprup Jun. 30 at 8:20 PM
$PATH a tease price to get u to buy shares so they can take it down to get stop loss shares 🆘 if u buy lock your shares down so they cant get cheap stop loss ones….there is a slight drift upward in price even though it goes up n down…. whatever entity thats trying to keep price down is hiding the fact they are in trouble…. extending the inevitable is what they have to do with ARR improving shares being removed by buyback programs they know they will have to cover soon…when it happens be ready…
0 · Reply
DizPlinTrading
DizPlinTrading Jun. 30 at 8:10 PM
$PATH Some profit taking at the end there, possibly some short who believes they caught a bargin. Either way, we are heading back to where we belong which is well above that 13 dollar mark from 2 weeks ago. You had a chance (again) in the 9s last week, that may have been the last chance you ever get 📈
0 · Reply
Carlos7144
Carlos7144 Jun. 30 at 7:59 PM
0 · Reply
rst1016
rst1016 Jun. 30 at 7:58 PM
$PATH hit 11. If u blinked u missed it. Pathetic
0 · Reply
iriepett
iriepett Jun. 30 at 7:57 PM
$PATH reversal signals ontop of reversal signals
0 · Reply
SoulFree
SoulFree Jun. 30 at 7:51 PM
$PATH Boom hello 11
0 · Reply